Jubilant Life Sciences has reported results for first quarter ended June 30, 2014.
The company has reported a net profit of Rs 203.72 crore as compared to a net loss of Rs 105.88 crore for the quarter ended June 30, 2013. Its total income from operations has increased by 25.82% to Rs 1036.24 for the quarter under review from Rs 823.56 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported a net profit after taxes, minority interest and share of profit / (loss) of associates of Rs 4.28 crore for the quarter as compared to a net loss of Rs 52.62 crore for the same quarter in the previous year. Its total income from operations has increased by 8.38% at Rs 1473.13 crore for quarter under review as compared to Rs 1359.27 crore for the quarter ended June 30, 2013.
